Clara Foodsは、酵素生産における持続可能性と倫理的懸念に対処するため、商用利用可能な世界初の動物由来フリー・ペプシンを開発しました。この製品は機能性能を維持し、ビーガン、ハラル、コーシャの要件を満たす食品および医薬品用途に適しています。この革新は、ペプシン市場における代替生産方法へのシフトを強調しています。
Clara Foodsは、商用利用可能な世界初の動物由来フリー・ペプシンの開発により、酵素技術における画期的な進歩を発表しました。このペプシンは、タンパク質分解に不可欠なプロテオライシス酵素であり、持続可能性と倫理的調達の主要な課題に対処しつつ、酵素の機能性能を維持します。
AIによるレポート AIによって生成された画像
A health ministry expert panel has conditionally approved two regenerative medicine products derived from induced pluripotent stem (iPS) cells for treating Parkinson's disease and severe heart disease. This marks a potential world first in commercializing Nobel Prize-winning stem cell technology. The approval, based on small-scale clinical trials confirming safety and presumed efficacy, requires post-market verification within seven years.
Functionality, convenience and value remain core drivers of innovation in the global food and beverage market, according to Innova’s Top Ten Trends of 2026. Affordability concerns are influencing retailers' strategies, while trends like plant-based proteins and occasion-based products gain prominence. Brands are also targeting senior health needs amid an ageing population.
AIによるレポート
Researchers at Flinders University have developed a thin, flexible film using milk protein, starch, and nanoclay that fully breaks down in soil within 13 weeks. The material aims to serve as an eco-friendly alternative to single-use plastics for food packaging. The study, published in Polymers, highlights its potential to reduce plastic pollution.
Researchers at Shandong University have modified the probiotic bacterium Escherichia coli Nissle 1917 to produce the anticancer drug Romidepsin directly in tumors. In mouse models of breast cancer, the engineered bacteria accumulated in tumors and released the drug. The findings were published on March 17 in PLOS Biology.
AIによるレポート
Following an expert panel's recommendation last month, Japan's Health, Labor and Welfare Ministry on March 6 conditionally approved two iPS cell-derived regenerative medicines—the world's first commercialized such treatments—for severe heart failure and Parkinson's disease. The products carry conditions and time limits, with pricing and insurance coverage decisions next; sales could begin as early as summer 2026.
Researchers at Caltech have discovered how viruses infect bacteria by disabling a key protein called MurJ, essential for cell wall construction. This mechanism, revealed through high-resolution imaging, suggests a new approach to combating antibiotic-resistant superbugs. The findings highlight convergent evolution in unrelated viruses blocking MurJ similarly.
AIによるレポート
Three students from Seattle's Bush School have developed MooBlue, a business idea using red seaweed to reduce methane emissions from cattle without altering beef production. Their pitch in a school entrepreneurship competition impressed judge Mitch Ratcliffe, leading to a podcast discussion on the concept's potential. The initiative targets harvesting invasive seaweed from the Mediterranean and creating an oil-based feed additive for farms.